Human T-lymphotropic virus type 1 (HTLV-I) has been shown to spread worldwide and to be responsible for distinct systemic diseases, namely adult T-celi leukaemia and HTLV-Iassociated myelopathy. Immune-mediated, inflammatory lesions in the lungs, joints, and lacrimal glands (Sjbgren's syndrome) are also suggested to be associated with the retrovirus. We studied seroprevalence of antibodies to HTLV-I in patients with various ocular disorders who are residents of south-west Japan, one of the endemic areas of HTLV 
Human T-lymphotropic virus type 1 (HTLV-I) is a recently defined retrovirus that may cause malignant disease of the blood (adult T-cell leukaemia),'-3 and chronic neurological disease (HTLV-I-associated myelopathy or tropical spastic paraparesis).45 More recent studies also indicate that a diverse group of aetiologically unknown clinical disorders are probably associated with HTLV-I infection as well, including pulmonary alveolitis, Sjogren's syndrome, and arthropathy. 58 HTLV-I has nothing to do with acquired immunodeficiency syndrome (AIDS), caused by a separate retrovirus HIV/HTLV-III,9 but has received much attention by many researchers. HTLV-I infection is worldwide, with endemic areas in south-west Japan, the Caribbean basin, central Africa, and Melanesia, and its main transmission routes include vertical transmission from infected mother to child, transfusion of infected blood, and sexual transmission.5 8 Ocular disorders in patients with HTLV-Iassociated systemic diseases include intraocular opportunistic infections such as cytomegalovirus retinitis in immunocompromised patients with adult T-cell leukaemia,'°" and non-infectious anterior uveitis, microvascular changes of the retina, and retinochoroidal atrophic lesions in patients with HTLV-I-associated myelopathy."- '5 Our hospital is located in south-west Japan, where HTLV-I infection is highly endemic, and we see many patients infected with the retrovirus. We have therefore performed a prospective study of HTLV-I seroprevalence in patients with various ocular diseases. The main purpose ofthis study was to search for any ocular disorder with an unusually high seroprevalence of HTLV-I infection.
Materials and methods A series of 310 patients, 158 men and 152 women, whose age ranged from 10 to 83 years (mean, 54 7, SD 17-3), were the subjects of a prospective study for HTLV-I infection. They were residents of Kagoshima prefecture of south-west Japan, and presented with various ocular diagnoses during a three-year period (Table 1) . Infection with HTLV-I was examined by assessment of serum antibodies against HTLV-I by the method of particle agglutination (PA method) as described elsewhere.'0 Agglutination reaction in serum of over 16 times dilution was regarded as seropositive, hence infected with the retrovirus. The patients also received a thorough ophthalmic and systemic examination.
The prevalence of HTLV-I infection in the general population of south-west Japan was studied by the PA method in a control group of 2484 adults -868 men and 1616 women, whose age ranged from 20 to 80 years (mean 55-4, SD 10-7).
The western blotting method (WB method) was also carried out on part of the material to confirm the accuracy ofdetection of the HTLV-I antibodies. Occasional materials showed inconsistency between the PA and the WB methods, though it was not so marked as to affect the conclusion in the present study.
The Mantel-Haenszel X2 test'6 was used for statistical comparison between ocular diseases and general population in consideration of the age factor.
Results Table 1 shows HTLV-I seroprevalence in patients with various ocular diseases, together with that in control adult residents of south-west Japan. Of 310 ophthalmic patients 72 (23-2%) were found to be infected with HTLV-I, the prevalence becoming higher with age. These results were compared with those for the general population of the same area, among whom 552 (22-2%) of 2484 control individuals were seropositive for HTLV-I, also with an increasingly high seropositivity with age. There was no significant difference in HTLV-I seroprevalence Seroprevalence ofantibodies toHTL V-I in patients with oculardisorders Of 32 patients with non-familial, isolated retinitis pigmentosa, eight (25 0%) had serum antibodies to HTLV-I, thus indicating no significant increase in HTLV-I seroprevalence over the control group. As regards keratoconjunctivitis sicca, four (15-4%) of 26 patients showed HTLV-I infection, representing no significant increase in HTLV-I prevalence.
Discussion
The prevalence of HTLV-I infection is strikingly high in south-west Japan. Yet the majority of infected adults remain carriers without any overt clinical disease, as epidemiological studies indicate that only one in 1000-2000 infected individuals may suffer from malignant disease of blood or chronic neurological disease.5 1 ' In any case we should be cautious in interpreting the high seroprevalence in ocular diseases in terms of the virus's causative role. Indeed most of the ocular diseases studied here showed no statistically significant increase in prevalence over the HTLV-I infection has received particular attention in recent years because, in addition to obvious systemic diseases (adult T-cell, leukaemia and HTLV-I-associated myelopathy), various aetiologically unknown disorders such as pulmonary alveolitis, arthropathy, Sjogren's syndrome, and myositis have been suggested to be involved in HTLV-I infection. A probable mechanism is thought to reside in immune mediated tissue reactions through polyclonal activation of T and B cell functions.5 8 In this connection the present observations appear of substantial interest, in that patients with aetiologically undefined, non-specific uveitis showed a significantly high seroprevalence of HTLV-I, and that the clinical features had an acute or subacute onset, consisted of granulomatous lesions in the anterior uvea, responded to local and/or systemic corticosteroid, and possibly ran a recurrent course. It is also emphasised that these patients remained otherwise intact in physical and laboratory studies. In particular we have found similar uveal disease in patients who had HTLV-I-associated myelopathy." 12 It would therefore be plausible that uveal inflammatory disease should occur as an isolated form in close association with HTLV-I infection, and we are inclined to hypothesise HTLV-I-associated uveitis (HAU), though its pathogenesis remains to be defined.
Isolated cotton-wool spots or microvascular changes of the retina are seen in some patients with HTLV-I-associated myelopathy." 14 In the present study we focused our attention on those patients who showed such retinal changes but did not show any accountable local or systemic disorder. One of nine such patients were found to be infected with HTLV-I. Further studies are justified to explore whether an isolated form of retinal microangiopathy is associated with HTLV-I infection.
We previously reported four cases of retinochoroidal degenerative changes which were found in 36 patients with HTLV-I-associated myelopathy, and discussed whether those cases represented a causative rather than a fortuitous association with HTLV-I infection, though the mechanism remained undefined. ' 
